These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16388330)

  • 21. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
    Yang L; Zhou X; Yang J; Yin X; Han L; Zhao D
    J Neuroimmunol; 2008 Aug; 199(1-2):10-7. PubMed ID: 18547651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell death in prion disease.
    Kretzschmar HA; Giese A; Brown DR; Herms J; Keller B; Schmidt B; Groschup M
    J Neural Transm Suppl; 1997; 50():191-210. PubMed ID: 9120419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prion protein fragment primes type 1 astrocytes to proliferation signals from microglia.
    Brown DR; Schmidt B; Kretzschmar HA
    Neurobiol Dis; 1998 Apr; 4(6):410-22. PubMed ID: 9666480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35.
    Hope J; Shearman MS; Baxter HC; Chong A; Kelly SM; Price NC
    Neurodegeneration; 1996 Mar; 5(1):1-11. PubMed ID: 8731376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of BAT3 alleviates prion protein fragment PrP106-126-induced neuronal apoptosis.
    Song ZQ; Yang LF; Wang YS; Zhu T; Zhou XM; Yin XM; Yao HQ; Zhao DM
    CNS Neurosci Ther; 2014 Aug; 20(8):737-47. PubMed ID: 24629137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amidation and structure relaxation abolish the neurotoxicity of the prion peptide PrP106-126 in vivo and in vitro.
    Bergström AL; Cordes H; Zsurger N; Heegaard PM; Laursen H; Chabry J
    J Biol Chem; 2005 Jun; 280(24):23114-21. PubMed ID: 15824101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells.
    Brown DR; Herms JW; Schmidt B; Kretzschmar HA
    Eur J Neurosci; 1997 Jun; 9(6):1162-9. PubMed ID: 9215699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
    Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
    Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
    J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126.
    Thellung S; Florio T; Villa V; Corsaro A; Arena S; Amico C; Robello M; Salmona M; Forloni G; Bugiani O; Tagliavini F; Schettini G
    Neurobiol Dis; 2000 Aug; 7(4):299-309. PubMed ID: 10964602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides.
    Agostinho P; Oliveira CR
    Eur J Neurosci; 2003 Mar; 17(6):1189-96. PubMed ID: 12670307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.
    Cronier S; Carimalo J; Schaeffer B; Jaumain E; Béringue V; Miquel MC; Laude H; Peyrin JM
    FASEB J; 2012 Sep; 26(9):3854-61. PubMed ID: 22661006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prion protein fragment 106-126 differentially induces heme oxygenase-1 mRNA in cultured neurons and astroglial cells.
    Rizzardini M; Chiesa R; Angeretti N; Lucca E; Salmona M; Forloni G; Cantoni L
    J Neurochem; 1997 Feb; 68(2):715-20. PubMed ID: 9003061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
    Kawahara M; Koyama H; Nagata T; Sadakane Y
    Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
    Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R
    Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity.
    Salmona M; Forloni G; Diomede L; Algeri M; De Gioia L; Angeretti N; Giaccone G; Tagliavini F; Bugiani O
    Neurobiol Dis; 1997; 4(1):47-57. PubMed ID: 9258911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells.
    Pietri M; Caprini A; Mouillet-Richard S; Pradines E; Ermonval M; Grassi J; Kellermann O; Schneider B
    J Biol Chem; 2006 Sep; 281(38):28470-9. PubMed ID: 16864581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact.
    Victoria GS; Arkhipenko A; Zhu S; Syan S; Zurzolo C
    Sci Rep; 2016 Feb; 6():20762. PubMed ID: 26857744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Sträussler-Scheinker disease amyloid protein.
    Fioriti L; Angeretti N; Colombo L; De Luigi A; Colombo A; Manzoni C; Morbin M; Tagliavini F; Salmona M; Chiesa R; Forloni G
    J Neurosci; 2007 Feb; 27(7):1576-83. PubMed ID: 17301166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.